Literature DB >> 25551360

The role of Cullin3-mediated ubiquitination of the catalytic subunit of PP2A in TRAIL signaling.

Jing Xu1, Jun-Ying Zhou, Zhengfan Xu, Dhong-Hyo Kho, Zhengping Zhuang, Avraham Raz, Gen Sheng Wu.   

Abstract

Protein phosphatase 2A (PP2A) is the major serine-threonine phosphatase that regulates a number of cell signaling pathways. PP2A activity is controlled partially through protein degradation; however, the underlying mechanism is not fully understood. Here we show that PP2A/C, a catalytic subunit of PP2A, is degraded by the Cullin3 (Cul3) ligase-mediated ubiquitin-proteasome pathway. In response to death receptor signaling by tumor-necrosis factor-related apoptosis-inducing ligand (TRAIL), PP2A/C, caspase-8 and Cul3, a subunit of the cullin family of E3 ligases, are recruited into the death-inducing signaling complex (DISC) where the Cul3 ligase targets PP2A/C for ubiquitination and subsequent degradation. Functionally, knockdown of PP2A/C expression by siRNA or pharmacological inhibition of PP2A activity increases TRAIL-induced apoptosis. In cancer cells that have developed acquired TRAIL resistance, PP2A phosphatase activity is increased, and PP2A/C protein is resistant to TRAIL-induced degradation. Thus, this work identifies a new mechanism by which PP2A/C is regulated by Cul3 ligase-mediated degradation in response to death receptor signaling and suggests that inhibition of PP2A/C degradation may contribute to resistance of cancer cells to death receptor-induced apoptosis.

Entities:  

Keywords:  Cullin3; PP2A; TRAIL; apoptosis resistance; ubiquitination

Mesh:

Substances:

Year:  2014        PMID: 25551360      PMCID: PMC4612120          DOI: 10.4161/15384101.2014.965068

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  40 in total

Review 1.  The novel functions of ubiquitination in signaling.

Authors:  Lijun Sun; Zhijian J Chen
Journal:  Curr Opin Cell Biol       Date:  2004-04       Impact factor: 8.382

2.  Identification of PP2A as a crucial regulator of the NF-kappaB feedback loop: its inhibition by UVB turns NF-kappaB into a pro-apoptotic factor.

Authors:  S Barisic; E Strozyk; N Peters; H Walczak; D Kulms
Journal:  Cell Death Differ       Date:  2008-06-27       Impact factor: 15.828

Review 3.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

4.  AtCHIP functions as an E3 ubiquitin ligase of protein phosphatase 2A subunits and alters plant response to abscisic acid treatment.

Authors:  Jinhua Luo; Guoxin Shen; Juqiang Yan; Cixin He; Hong Zhang
Journal:  Plant J       Date:  2006-05       Impact factor: 6.417

5.  B cell receptor-associated protein alpha4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A.

Authors:  K Murata; J Wu; D L Brautigan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

6.  Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family.

Authors:  R M Pitti; S A Marsters; S Ruppert; C J Donahue; A Moore; A Ashkenazi
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

7.  Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.

Authors:  M M Keane; S A Ettenberg; M M Nau; E K Russell; S Lipkowitz
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

8.  Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.

Authors:  Jing Xu; Jun-Ying Zhou; Wei-Zen Wei; Gen Sheng Wu
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

9.  Type-2A protein phosphatase activity is required to maintain death receptor responsiveness.

Authors:  Ann-Sofi Härmälä-Braskén; Andrey Mikhailov; Thomas S Söderström; Annika Meinander; Tim H Holmström; Zahi Damuni; John E Eriksson
Journal:  Oncogene       Date:  2003-10-23       Impact factor: 9.867

10.  BTB/POZ domain proteins are putative substrate adaptors for cullin 3 ubiquitin ligases.

Authors:  Rory Geyer; Susan Wee; Scott Anderson; John Yates; Dieter A Wolf
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970

View more
  9 in total

Review 1.  Developing TRAIL/TRAIL death receptor-based cancer therapies.

Authors:  Xun Yuan; Ambikai Gajan; Qian Chu; Hua Xiong; Kongming Wu; Gen Sheng Wu
Journal:  Cancer Metastasis Rev       Date:  2018-12       Impact factor: 9.264

2.  Anticancer activity of NOB1-targeted shRNA combination with TRAIL in epithelial ovarian cancer cells.

Authors:  Yang Lin; Tianmin Xu; Hong Teng; Manhua Cui
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  Targeting PP2A inhibits the growth of triple-negative breast cancer cells.

Authors:  Mohammed Hafiz Uddin; Julio M Pimentel; Madhumita Chatterjee; Joshu E Allen; Zhengping Zhuang; Gen Sheng Wu
Journal:  Cell Cycle       Date:  2020-02-03       Impact factor: 4.534

Review 4.  Chromatin-Bound Cullin-Ring Ligases: Regulatory Roles in DNA Replication and Potential Targeting for Cancer Therapy.

Authors:  Sang-Min Jang; Christophe E Redon; Mirit I Aladjem
Journal:  Front Mol Biosci       Date:  2018-03-13

5.  Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells.

Authors:  Ming Zhao; Erin W Howard; Amanda B Parris; Zhiying Guo; Qingxia Zhao; Zhikun Ma; Ying Xing; Bolin Liu; Susan M Edgerton; Ann D Thor; Xiaohe Yang
Journal:  Oncotarget       Date:  2017-07-19

6.  Sub-Chronic Microcystin-LR Liver Toxicity in Preexisting Diet-Induced Nonalcoholic Steatohepatitis in Rats.

Authors:  Tarana Arman; Katherine D Lynch; Michelle L Montonye; Michael Goedken; John D Clarke
Journal:  Toxins (Basel)       Date:  2019-07-09       Impact factor: 4.546

7.  Potassium Effects on NCC Are Attenuated during Inhibition of Cullin E3-Ubiquitin Ligases.

Authors:  Sathish K Murali; Robert Little; Søren B Poulsen; Mohammed Z Ferdaus; David H Ellison; James A McCormick; Robert A Fenton
Journal:  Cells       Date:  2021-12-29       Impact factor: 7.666

8.  Endothelial Cullin3 Mutation Impairs Nitric Oxide-Mediated Vasodilation and Promotes Salt-Induced Hypertension.

Authors:  Jing Wu; Shi Fang; Ko-Ting Lu; Gaurav Kumar; John J Reho; Daniel T Brozoski; Adokole J Otanwa; Chunyan Hu; Anand R Nair; Kelsey K Wackman; Larry N Agbor; Justin L Grobe; Curt D Sigmund
Journal:  Function (Oxf)       Date:  2022-04-08

Review 9.  A dynamic interface between ubiquitylation and cAMP signaling.

Authors:  Laura Rinaldi; Maria Sepe; Rossella Delle Donne; Antonio Feliciello
Journal:  Front Pharmacol       Date:  2015-09-04       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.